Role of cardiac troponin testing in percutaneous transluminal coronary angioplasty

REFERENCES

• Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined a consensus docu-ment of the Joint European Society of Cardiology/ American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959–69.
   PubMed Web of Science ®Google Scholar
• Wu AHB, Valdes R Jr, Apple FS, Gomet T, Stone MA, Mayfield-Stokes S, Ingersoll AM, Wiler B. Cardiac troponin T immunoassay for diagnosis of acute myocardial infarction and detection of minor myocardial injury. Clin Chem 1994; 40: 900–7.
   Google Scholar
• Mair J, Morandel D, Genser N, Lechleitner P, Dientsl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, Creatine kinase isoform ratios and cardiac tropo-nin I and T for acute myocardial infarction. Clin Chem 1995; 41: 1266–72.
   PubMed Web of Science ®Google Scholar
• Adams JE, Abendschein DR, Jaffe AS. Bio-chemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circula-tion 1993; 88: 750–63.
   Google Scholar
• Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. It's time for a change to a troponin standard. Circulation 2000; 102: 1216–20.
   Google Scholar
• Braunwald E, Antman EM, Beasley JW, Calif RM, Cheitlin MD, Hochman JS, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE III, Steward DE, Theroux P, Gibbons RJ, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive sum-mary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102: 1193–209.
   Google Scholar
• Apple FS, Falahati A, Paulsen PR, Miller EA, Sharkey SW. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem 1997; 43: 2047–51.
   Google Scholar
• Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651–7.
   Google Scholar
• Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Salter LF, Kent KM, Stone GW, Leon MB. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions intravascular ultrasound study of 2256 patients. Circulation 2000; 101: 604–10.
   Google Scholar
• Hunt AC, Chow SL, Shu MF, Chilton DC, Cummins B, Cummins P. Release of creatine kinase MB and cardiac specific troponin-I fol-lowing percutaneous transcoronary angioplasty. Eur Heart J 1991; 12: 690–4.
   PubMedGoogle Scholar
• Katoh H, Shimada T, Sano K, Inove S, Kitamura J, Sakane T, Murakami Y, Ishibashi Y, Karino K, Masuda J. Troponin T in the coronary sinus and percutaneous transluminal coronary angioplasty related myocardial injury. Clin Exp Pharmacol Physiol 2000; 27: 14–7.
   Google Scholar
• Ravkilde J, Nissen H, Mickley H, Andersen P, Thayssen P, Horder M. Cardiac troponin T and CK MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 127: 13–9.
   Google Scholar
• Stone GW, Mehran R, Dangas G, Lansky AJ, Komowski R, Leon M. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percuta-neous intervention: a device specific analysis of 7147 patients. Circulation 2001; 104: 642–7.
   PubMed Web of Science ®Google Scholar
• Abbas SA, Glazier JJ, Wu AH, Dupont C, Green SF, Pearsall LA, Waters DD, McKay RG. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol 1996; 19: 782–6.
   PubMed Web of Science ®Google Scholar
• Bonz AW, Lengenfelder B, Strotmann J, Held S, Turschner O, Harre K, Wacker C, Walker C, Kochsiek N, Meesmann M, Neyses L, Schanzenbacher P, Ertl G, Voelker W. Effect of additional temporary glycoprotein Hb/IIIa recep-tor inhibition on troponin release in elective percutaneous coronary interventions after pre-treatment with aspirin and clopidogrel (TOP-STAR trial). J Am Coll Cardiol 2002; 40: 662–8.
   PubMed Web of Science ®Google Scholar
• Bairn D, Wahr D, George B, Leon M, Greenberg J, Cutlip D, Kaya U, Popma J, Ho K, Kuntz Ron behalf of the saphenous vein graft angioplasty free of emboli randomized (SAFER) trial investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphe-nous vein aorto-coronary bypass grafts. Circulation 2002; 105: 1285–90.
   Google Scholar
• Chan AW, Quinn MJ, Bhatt DL, Chew DP, Moliterno DJ, Topol EJ, Ellis GS. Mortality benefit of beta-blockade after elective percuta-neous coronary intervention. J Am Coll Cardiol 2002; 40: 669–75.
   Google Scholar
• Johansen O, Brekke M, Stromme JH, Valen V, Seljeflot I, Skjaeggestad O, Amesen. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measure-ments. Eur Heart J 1998; 19: 112–7.
   Google Scholar
• Stromme JH, Johansen O, Brekke M, Seljeflot I, Amesen H. Markers of myocardial injury in blood following PTCA: a comparison of CK MB, cardio-specific troponin T and troponin I. Scand J Clin Lab Invest 1998; 58: 693–700.
   Google Scholar
• Karim M, Shinn M, Oskarsson H, Windle J, Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1995; 76: 521–3.
   Google Scholar
• Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: detection by cardiac troponins. Catheter Cardiovasc Interv 2001; 53: 188–92.
   PubMed Web of Science ®Google Scholar
• Talasz H, Genser N, Mair J, Dworzak E, Friedrich G, Moes N, Muhlberger VC, Puschendorf B. Side-branch occlusion during percutaneous trans-luminal coronary angioplasty. Lancet 1992; 339: 1380� 2.
   Google Scholar
• Genser M, Mair J, Talasz H, Puschendorf B, Calzolari C, Lame C, Friedrich G, Moes N, Muehlberger V. Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury. Clin Chim Acta 1997; 265: 207–17.
   Google Scholar
• Vecchia L, Bedogni F, Finocchi G, Mezzena G, Martini M, Sartori M, Castellani A, Soffiati G, Vincenzi M. Troponin T, troponin I and creatine kinase MB mass after elective coronary stenting. Coron Artery Dis 1996; 7: 535–40.
   Google Scholar
• Shyu K, Kuan P, Cheng J, Hung C. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coron-ary angioplasty with or without stenting. Am Heart J 1998; 135: 862–7.
   Google Scholar
• Garbarz E, lung B, Lefevre G, Makita Y, Farah B, Michaud P, Graine H, Vahanian A. Frequency and prognostic value of cardiac troponin I elevation after stenting. Am J Cardiol 1999; 84: 515–8.
   Google Scholar
• Ohnishi N, Iwasaki K, Kusachi S, Hirami R, Mataro S, Ohnishi H, Takeda K, Kita T, Sakakibara N, Tsuji T. Low incidence of minor myocardial damage associated with coronary stenting detected by serum troponin T comparable to that with balloon coronary angioplasty. Jpn Heart J 1998; 39: 139–46.
   PubMedGoogle Scholar
• Bertinchant J, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, Brunet J, Poirey S, Wittenberg O, Pernel I, Nigond J. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84: 51–7.
   Google Scholar
• Attali P, Aleil P, Petitpas G, DePoli F, Wuillermin A, Cazenave JP, Mossard JM. Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol 1998; 21: 353–6.
   Google Scholar
• Fuchs S, Gruberg L, Singh S, Stabile E, Duncan C, Wu H, Waksman R, Satler LF, Pichard AD, Kent KM, Kornowski R. Prognostic value of cardiac troponin I re-elevation following percuta-neous coronary intervention in high-risk patients with acute coronary syndromes. Am J Cardiol 2001; 88: 129–33.
   Google Scholar
• Ricchiuti V, Shear W, Henry T, Paulsen P, Miller E, Apple F. Monitoring plasma cardiac troponin I for the detection of myocardial injury after percutaneous transluminal coronary angioplasty. Clin Chim Acta 2000; 302: 161–70.
   PubMed Web of Science ®Google Scholar
• Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, Urban P, den Heijer P, Koch K, Simon R, Morice MC, Crean P, Bonnier H, Wijns W, Danchin N, Bourdonnec C, Morel MA. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of the Benestent trial. Benestent Study Group. J Am Coll Cardiol 1996; 27: 256–61.
   Google Scholar
• Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin T and I CK MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem 2000; 37: 764–9.
   Google Scholar
• Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, Muller-Bardoff M, Richardt G, Katus HA. Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percuta-neous intervention for acute ST-segment elevation myocardial infarction. Crit Care Med 2002; 30: 2229� 35.
   Google Scholar
• Fuchs S, Kornowski R, Mehran R, Lansky J, Satler F, Pichard D, Kent M, Clark E, Stone G, Leon M. Prognostic value of cardiac troponin-I levels following catheter-based coronary interven-tions. Am J Cardiol 2000; 85: 1077–82.
   PubMed Web of Science ®Google Scholar
• Abdelmeguid A, Topol E. The myth of the myocardial "infarctlet" during percutaneous cor-onary revascularization procedures. Circulation 1996; 94: 3369–75.
   Google Scholar
• Akkerhuis K, Alexander J, Tardiff B, Boersma E, Harrington R, Lincoff M, Simoons M. Minor myocardial damage and prognosis, are sponta-neous and percutaneous coronary intervention-related events different? Circulation 2002; 105: 554–6.
   Google Scholar
• Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, Noe A, Matern G, Kuebler W. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902–12.
   PubMed Web of Science ®Google Scholar
• Jaffe AS, Landt Y, Parvin CA, Abedschein DR, Geltman EM, Ladenson JH. Comparative sensi-tivity of cardiac troponin I and lactate dehydro-genase isoenzymes for diagnosis of acute myocardial infarction. Clin Chem 1996; 42: 1770–6.
   PubMed Web of Science ®Google Scholar
• Apple F. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999; 45: 18–20.
   Google Scholar
• Katrukha AG, Bereznikova AV, Filatov V, Esakova TV, Kolosova OV, Petterson K, Lovgren T, Bulargina TV, Trifonov IR, Gratsiansky NA, Pulkki K, Voipio-Pulkki LM, Gusev NB. Degradation of cardiac troponin I: implications for reliable immunodetection. Clin Chem 1998; 44: 2433–40.
   Google Scholar
• Wu AHB, Feng YJ, Moore R, Apple FS, Mc Pherson PH, Buechler KF, Bodor G. Character-ization of cardiac troponin subunit release into serum following acute myocardial infarction, and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on Standardization. Clin Chem 1998; 44: 1198–208.
   Google Scholar
• Christenson RH, Duh SH, Apple FS, Bodor G, Bunk DM, Dalluge J, Panteghini M, Potter JD, Welch MJ, Wu AH, Kahn SE. Standardization of cardiac troponin I assays: round robin of ten candidate reference materials. Clin Chem 2001; 47: 431–7.
   Google Scholar